Acorah Software Products - Accounts Production 14.5.601 false true 31 January 2023 1 February 2022 false true No description of principal activity 1 February 2023 31 January 2024 31 January 2024 09955679 Mr James Gray iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 09955679 2023-01-31 09955679 2024-01-31 09955679 2023-02-01 2024-01-31 09955679 frs-bus:PrivateLimitedCompanyLtd 2023-02-01 2024-01-31 09955679 frs-bus:FilletedAccounts 2023-02-01 2024-01-31 09955679 frs-bus:Micro-entities 2023-02-01 2024-01-31 09955679 frs-bus:AuditExempt-NoAccountantsReport 2023-02-01 2024-01-31 09955679 frs-bus:Director1 2023-02-01 2024-01-31 09955679 2022-01-31 09955679 2023-01-31 09955679 2022-02-01 2023-01-31
Registered number: 09955679
Dashmed Limited
Unaudited Financial Statements
For The Year Ended 31 January 2024
Sharpe Medical Accounting Ltd
Balance Sheet
Registered number: 09955679
2024 2023
£ £
Current assets 1 1
NET CURRENT ASSETS 1 1
TOTAL ASSETS LESS CURRENT LIABILITIES 1 1
NET ASSETS 1 1
CAPITAL AND RESERVES 1 1

Notes

1. General Information
Dashmed Limited is a private company, limited by shares, incorporated in England & Wales, registered number 09955679 . The registered office is Normanby Gateway, Lysaghts Way, Scunthorpe, North Lincolnshire, DN15 9YG.
2. Average Number of Employees
Average number of employees, including directors, during the year was: 1 (2023: 1)
1 1
Page 0
Page 1
For the year ending 31 January 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies' regime.
On behalf of the board
Mr James Gray
Director
08/04/2024